Yu‐Jih Su

2.8k citations
128 papers · 2.0k indexed · h-index 26
Topics
Systemic Lupus Erythematosus Research (22 papers)Rheumatoid Arthritis Research and Therapies (12 papers)Bone health and osteoporosis research (12 papers)
Partner nations
TaiwanChinaUnited States

In The Last Decade

Yu‐Jih Su

125 papers receiving 2.0k citations

Peers

Yu‐Jih Su
Comparison fields: 5 of 128
  • Molecular Biology 458
  • Rheumatology 375
  • Physiology 359
  • Epidemiology 353
  • Immunology 322
Replace Francesco Ursini with:
Francesco Ursini Italy
Pier Leopoldo Capecchi Italy
Maria Teresa Garcı́a-Unzueta Spain
Erik Øie Norway
Bert Bravenboer Netherlands
Feng Xu China
Pietro Enea Lazzerini Italy
Praveen Surendran United Kingdom
Maria Alevizaki Greece
Yu‐Jih Su relative to Francesco Ursini Italy Francesco Ursini's profile →
Citations per field
00.5×2.7×
Francesco Ursini · 1×
Citations per year

Countries citing papers authored by Yu‐Jih Su

Since Specialization
Citations

This map shows the geographic impact of Yu‐Jih Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Jih Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Jih Su more than expected).

Fields of papers citing papers by Yu‐Jih Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu‐Jih Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Jih Su. The network helps show where Yu‐Jih Su may publish in the future.

Co-authorship network of co-authors of Yu‐Jih Su

This figure shows the co-authorship network connecting the top 25 collaborators of Yu‐Jih Su. A scholar is included among the top collaborators of Yu‐Jih Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu‐Jih Su. Yu‐Jih Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 3
4 2
5 6
6 4
7 7
8 6
9 20
10 7
11 33
12 13
13 5
14 1
15 8
16 3
17 14
18 4
19 24
20 1

About Yu‐Jih Su

Yu‐Jih Su is a scholar working on Rheumatology, Orthopedics and Sports Medicine and Immunology, having authored 128 papers that have together received 2.0k indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (22 papers), Rheumatoid Arthritis Research and Therapies (12 papers) and Bone health and osteoporosis research (12 papers). The work is most often cited by research in Rheumatology (375 citations), Neurology (282 citations) and Orthopedics and Sports Medicine (142 citations). Yu‐Jih Su has collaborated with scholars based in Taiwan, China and United States. Frequent co-authors include Nai‐Wen Tsai, Cheng‐Hsien Lu, Ben‐Chung Cheng, Wei-Che Lin, Chia‐Te Kung, Hung‐Chen Wang, Chih-Min Su, Chung‐Yuan Hsu, Shan‐Fu Yu and Wen‐Neng Chang. Their work appears in journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Journal of Hazardous Materials.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026